|
Market Closed -
OTC Markets
09:53:26 2021-11-09 EST
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
+9,900.00% | +9,900.00% |
| Market Cap | 1.04M 899K 848K 769K 1.44M 99.39M 1.45M 10.13M 3.9M 50.42M 3.89M 3.81M 160M | P/E 2015 |
-0.75x | P/E 2016 | -0.29x |
|---|---|---|---|---|---|
| Enterprise Value | -11.07M -9.59M -9.05M -8.21M -15.41M -1.06B -15.52M -108M -41.67M -538M -41.59M -40.67M -1.71B | EV / Sales 2015 |
-616,781,247x | EV / Sales 2016 | - |
| Free-Float |
100% | Yield 2015 * |
-
| Yield 2016 | - |
| 1 day | +9,900.00% | ||
| 1 week | +9,900.00% | ||
| Current month | +9,900.00% | ||
| 1 month | +9,900.00% | ||
| 3 months | +9,900.00% | ||
| 6 months | +9,900.00% | ||
| Current year | +9,900.00% |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0 | |
| 10 years | 0 | 0 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Talari
CEO | Chief Executive Officer | 64 | 2014-08-13 |
John Verghese
COO | Chief Operating Officer | 66 | - |
Karin Rohret
AUD | Comptroller/Controller/Auditor | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sam Talari
CHM | Chairman | 64 | 2014-08-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +9,900.00% | +9,900.00% | +9,900.00% | +9,900.00% | 8.39K | ||
| +1.57% | -4.11% | +41.74% | -4.64% | 78.04B | ||
| +1.89% | +0.78% | +523.95% | +30.03% | 57.48B | ||
| +0.41% | -1.38% | -15.70% | -35.60% | 57.4B | ||
| +0.35% | -3.14% | -11.03% | +26.34% | 48.81B | ||
| +2.38% | +0.10% | +1.49% | +155.34% | 45.5B | ||
| +0.10% | -1.57% | +50.05% | -15.20% | 32.08B | ||
| +0.59% | -3.60% | +47.04% | +92.49% | 24.62B | ||
| -0.52% | -4.29% | +0.78% | +145.79% | 20.77B | ||
| +2.24% | -0.40% | +66.12% | +100.09% | 15.75B | ||
| Average | +990.72% | -2.63% | +1,060.45% | +1,039.46% | 38.04B | |
| Weighted average by Cap. | +0.83% | -2.52% | +94.16% | +36.98% |
| 2015 | 2016 | |
|---|---|---|
| Net sales | 0.05 0.05 0.04 0.04 0.08 5.17 0.08 0.53 0.2 2.62 0.2 0.2 8.34 | - |
| Net income | -1.41M -1.22M -1.15M -1.04M -1.96M -135M -1.97M -13.72M -5.29M -68.32M -5.28M -5.16M -217M | -644K -558K -527K -478K -897K -61.75M -903K -6.29M -2.42M -31.33M -2.42M -2.37M -99.6M |
| Net Debt | -34.28M -29.71M -28.03M -25.43M -47.71M -3.29B -48.05M -335M -129M -1.67B -129M -126M -5.3B | -12.11M -10.49M -9.9M -8.98M -16.85M -1.16B -16.97M -118M -45.57M -589M -45.48M -44.48M -1.87B |
Employees
8
Sector
Pharmaceuticals
- Stock Market
- Stocks
- FWDG Stock
Select your edition
All financial news and data tailored to specific country editions
















